Skip to content
DataLookout
Menu

RADPAINT-2NCT04910308

RAdiotherapy With FDG-PET Guided Dose-PAINTing for Primary Head and Neck

StatusCompleted
PhaseNot applicable
Primary completion
Track this trial

Free. We email you which fields changed when ClinicalTrials.gov updates this record.

Record History

All 7 versions: 5 with changes below, 2 re-verified with no change. See every version on ClinicalTrials.gov ↗

  1. Notable Eligibility criteria revised Show 5 more changesShow less
    • Trial completed
    • Study completion date changed from estimate of Aug 2025 to Jun 20, 2025
    • Secondary endpoints: details revised at 3 of 5 entries
    • Study description revised
    • Publications: details revised at 1 of 1 entry
  2. Minor Study completion date: Dec 31, 2024 to Aug 2025v6
  3. Minor Trial status: Recruiting to Active, Not Recruiting
    • Primary completion date changed from estimate of Jun 30, 2022 to May 27, 2022
    • Site details revised
    v4
  4. Notable Trial status: Not Yet Recruiting to Recruiting
    • Primary completion date: Jun 30, 2021 to Jun 30, 2022
    • Start date changed from estimate of Jun 1, 2021 to Jul 1, 2021
    v3
  5. Study First Submitted
  • Notable: the plan changed
  • Minor: routine updates

Endpoints

Primary

Late toxicity - mucosal ulcer
Timeframe: 1 year
Acute or late toxicity
Timeframe: 1 year

Secondary (5)

Acute toxicity
Late toxicity
Loco-regional control
Disease free survival
Overall survival

Arms and interventions

Dose paintingExperimental

Dose painting

Radiation: FDG-PET guided dose painting

Sites

1 site in 1 country

  • Oslo University HospitalOslo, Norway